-
1
-
-
65249175011
-
Osteoporosis awareness protocol for patients with fragility fractures
-
Al-Dabagh H, Archer J, Newton M, Kwagyan J, Nunlee-Bland G. Osteoporosis awareness protocol for patients with fragility fractures. J Natl Med Assoc. 2009;101:145-150.
-
(2009)
J Natl Med Assoc
, vol.101
, pp. 145-150
-
-
Al-Dabagh, H.1
Archer, J.2
Newton, M.3
Kwagyan, J.4
Nunlee-Bland, G.5
-
3
-
-
60849120159
-
Osteoporosis: Information from your family doctor
-
American Academy of Family Physicians
-
American Academy of Family Physicians. Osteoporosis: information from your family doctor. Am Fam Physician. 2009;79: 201-202.
-
(2009)
Am Fam Physician
, vol.79
, pp. 201-202
-
-
-
4
-
-
42649112056
-
Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD position development conference
-
Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Lewiecki EM, Silverman S. Official positions of the International Society for Clinical Densitometry and executive summary of the 2007 ISCD position development conference. J Clin Densitom. 2008;11:75-91.
-
(2008)
J Clin Densitom
, vol.11
, pp. 75-91
-
-
Baim, S.1
Binkley, N.2
Bilezikian, J.P.3
Kendler, D.L.4
Hans, D.B.5
Lewiecki, E.M.6
Silverman, S.7
-
5
-
-
0034456603
-
Low levels of estradiol are associated with vertebral fractures in older men, but not women: The Rancho Bernardo Study
-
DOI 10.1210/jc.85.1.219
-
Barrett-Connor E, Mueller JE, von Muhlen DG, Laughlin GA, Schneider DL, Sartoris DJ. Low levels of estradiol are associated with vertebral fractures in older men, but not women: The Rancho Bernardo Study. J Clin Endocrinol Metab. 2000;85:219-223. (Pubitemid 32268817)
-
(2000)
Journal of Clinical Endocrinology and Metabolism
, vol.85
, Issue.1
, pp. 219-223
-
-
Barrett-Connor, E.1
Mueller, J.E.2
Von Muhlen, D.G.3
Laughlin, G.A.4
Schneider, D.L.5
Sartoris, D.J.6
-
6
-
-
78549284873
-
Effects of estrogen on fracture healing in mice
-
Beil FT, Barvencik F, Gebauer M, Seitz S, Rueger JM, Ignatius A, Pogoda P, Schinke T, Amling M. Effects of estrogen on fracture healing in mice. J Trauma. 2010;69:1259-1265.
-
(2010)
J Trauma
, vol.69
, pp. 1259-1265
-
-
Beil, F.T.1
Barvencik, F.2
Gebauer, M.3
Seitz, S.4
Rueger, J.M.5
Ignatius, A.6
Pogoda, P.7
Schinke, T.8
Amling, M.9
-
7
-
-
33645225936
-
Osteoporosis intervention in ambulatory patients with previous hip fracture: A multicentric, nationwide Italian survey
-
Carnevale V, Nieddu L, Romagnoli E, Bona E, Piemonte S, Scillitani A, Minisola S. Osteoporosis intervention in ambulatory patients with previous hip fracture: a multicentric, nationwide Italian survey. Osteoporos Int. 2006;17:478-483.
-
(2006)
Osteoporos Int
, vol.17
, pp. 478-483
-
-
Carnevale, V.1
Nieddu, L.2
Romagnoli, E.3
Bona, E.4
Piemonte, S.5
Scillitani, A.6
Minisola, S.7
-
8
-
-
0033550968
-
Mortality after all major types of osteoporotic fracture in men and women: An observational study
-
DOI 10.1016/S0140-6736(98)09075-8
-
Center JR, Nguyen TV, Schneider D, Sambrook PN, Eisman JA. Mortality after all major types of osteoporotic fracture in men and women: an observational study. Lancet. 1999;353:878-882. (Pubitemid 29126875)
-
(1999)
Lancet
, vol.353
, Issue.9156
, pp. 878-882
-
-
Center, J.R.1
Nguyen, T.V.2
Schneider, D.3
Sambrook, P.N.4
Eisman, J.A.5
-
9
-
-
6344294751
-
Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study
-
DOI 10.1359/JBMR.040109
-
Chang KP, Center JR, Nguyen TV, Eisman JA. Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res. 2004;19:532-536. (Pubitemid 41071211)
-
(2004)
Journal of Bone and Mineral Research
, vol.19
, Issue.4
, pp. 532-536
-
-
Chang, K.P.1
Center, J.R.2
Nguyen, T.V.3
Eisman, J.A.4
-
11
-
-
0036679350
-
Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis
-
Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group
-
Cranney A, Tugwell P, Zytaruk N, Robinson V, Weaver B, Adachi J, Wells G, Shea B, Guyatt G; Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group. Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocr Rev. 2002;23:524-528.
-
(2002)
Endocr Rev
, vol.23
, pp. 524-528
-
-
Cranney, A.1
Tugwell, P.2
Zytaruk, N.3
Robinson, V.4
Weaver, B.5
Adachi, J.6
Wells, G.7
Shea, B.8
Guyatt, G.9
-
12
-
-
0010496839
-
Esophagitis associated with the use of alendronate
-
DOI 10.1056/NEJM199610033351403
-
de Groen PC, Lubbe DF, Hirsch LJ, Daifotis A, Stephenson W, Freedholm D, Pryor-Tillotson S, Seleznick MJ, Pinkas H, Wang KK. Esophagitis associated with the use of alendronate. N Engl J Med. 1996;335:1016-1021. (Pubitemid 26338731)
-
(1996)
New England Journal of Medicine
, vol.335
, Issue.14
, pp. 1016-1021
-
-
De Groen, P.C.1
Lubbe, D.F.2
Hirsch, L.J.3
Daifotis, A.4
Stephenson, W.5
Freedholm, D.6
Pryor-Tillotson, S.7
Seleznick, M.J.8
Pinkas, H.9
Wang, K.K.10
-
13
-
-
18544381541
-
Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial
-
DOI 10.1210/jc.87.8.3609
-
Delmas PD, Ensrud KE, Adachi JD, Harper KD, Sarkar S, Gennari C, Reginster JY, Pols HA, Recker RR, Harris ST, Wu W, Genant HK, Black DM, Eastell R; Multiple Outcomes of Raloxifene Evaluation Investigators. Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial. J Clin Endocrinol Metab. 2002;87:3609-3617. (Pubitemid 34879503)
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.8
, pp. 3609-3617
-
-
Delmas, P.D.1
Ensrud, K.E.2
Adachi, J.D.3
Harper, K.D.4
Sarkar, S.5
Gennari, C.6
Reginster, J.-Y.7
Pols, H.A.P.8
Recker, R.R.9
Harris, S.T.10
Wu, W.11
Genant, H.K.12
Black, D.M.13
Eastell, R.14
-
14
-
-
2342489375
-
Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men
-
DOI 10.1530/eje.0.1500539
-
Duschek EJ, Gooren LJ, Netelenbos C. Effects of raloxifene on gonadotrophins, sex hormones, bone turnover and lipids in healthy elderly men. Eur J Endocrinol. 2004;150:539-546. (Pubitemid 38584706)
-
(2004)
European Journal of Endocrinology
, vol.150
, Issue.4
, pp. 539-546
-
-
Duschek, E.J.J.1
Gooren, L.J.2
Netelenbos, C.3
-
15
-
-
0032425188
-
Osteoporosis in men. New insights into aetiology, pathogenesis, prevention and management
-
DOI 10.2165/00002512-199813060-00002
-
Ebeling PR. Osteoporosis in men: new insights into aetiology, pathogenesis, prevention and management. Drugs Aging. 1998; 13:421-434. (Pubitemid 29002720)
-
(1998)
Drugs and Aging
, vol.13
, Issue.6
, pp. 421-434
-
-
Ebeling, P.R.1
-
16
-
-
41649095977
-
Clinical practice: Osteoporosis in men
-
Ebeling PR. Clinical practice: osteoporosis in men. N Engl J Med. 2008;358:1474-1482.
-
(2008)
N Engl J Med
, vol.358
, pp. 1474-1482
-
-
Ebeling, P.R.1
-
17
-
-
44649154647
-
Secondary contributors to bone loss in osteoporosis related hip fractures
-
Edwards BJ, Langman CB, Bunta AD, Vicuna M, Favus M. Secondary contributors to bone loss in osteoporosis related hip fractures. Osteoporos Int. 2008;19:991-999.
-
(2008)
Osteoporos Int
, vol.19
, pp. 991-999
-
-
Edwards, B.J.1
Langman, C.B.2
Bunta, A.D.3
Vicuna, M.4
Favus, M.5
-
18
-
-
0034919369
-
Exploring the biological contributions to human health: Does sex matter?
-
Exploring the biological contributions to human health: does sex matter? J Womens Health Gend Based Med. 2001;10:433-439.
-
(2001)
J Womens Health Gend Based Med
, vol.10
, pp. 433-439
-
-
-
19
-
-
23744458930
-
The near absence of osteoporosis treatment in older men with fractures
-
DOI 10.1007/s00198-005-1950-0
-
Feldstein AC, Nichols G, Orwoll E, Elmer PJ, Smith DH, Herson M, Aickin M. The near absence of osteoporosis treatment in older men with fractures. Osteoporos Int. 2005;16:953-962. (Pubitemid 41127105)
-
(2005)
Osteoporosis International
, vol.16
, Issue.8
, pp. 953-962
-
-
Feldstein, A.C.1
Nichols, G.2
Orwoll, E.3
Elmer, P.J.4
Smith, D.H.5
Herson, M.6
Aickin, M.7
-
20
-
-
33749541914
-
Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men
-
DOI 10.1210/jc.2006-0173
-
Fink HA, Ewing SK, Ensrud KE, Barrett-Connor E, Taylor BC, Cauley JA, Orwoll ES. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J Clin Endocrinol Metab. 2006;91:3908-3915. (Pubitemid 44536863)
-
(2006)
Journal of Clinical Endocrinology and Metabolism
, vol.91
, Issue.10
, pp. 3908-3915
-
-
Fink, H.A.1
Ewing, S.K.2
Ensrud, K.E.3
Barrett-Connor, E.4
Taylor, B.C.5
Cauley, J.A.6
Orwoll, E.S.7
-
21
-
-
71249150782
-
Osteoporosis in males and females: Is there really a difference?
-
Guggenbuhl P. Osteoporosis in males and females: is there really a difference? Joint Bone Spine. 2009;76:595-601.
-
(2009)
Joint Bone Spine
, vol.76
, pp. 595-601
-
-
Guggenbuhl, P.1
-
22
-
-
69449104970
-
Closing the osteoporosis care gap: Increased osteoporosis awareness among geriatrics and rehabilitation teams
-
Jul 14
-
Haaland DA, Cohen DR, Kennedy CC, Khalidi NA, Adachi JD, Papaioannou A. Closing the osteoporosis care gap: increased osteoporosis awareness among geriatrics and rehabilitation teams. BMC Geriatr. 2009 Jul 14;9:28.
-
(2009)
BMC Geriatr
, vol.9
, pp. 28
-
-
Haaland, D.A.1
Cohen, D.R.2
Kennedy, C.C.3
Khalidi, N.A.4
Adachi, J.D.5
Papaioannou, A.6
-
23
-
-
0033039349
-
Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis
-
DOI 10.1002/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2-U
-
Hochberg MC, Ross PD, Black D, Cummings SR, Genant HK, Nevitt MC, Barrett-Connor E, Musliner T, Thompson D. Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis: Fracture Intervention Trial Research Group. Arthritis Rheum. 1999;42:1246-1254. (Pubitemid 29268962)
-
(1999)
Arthritis and Rheumatism
, vol.42
, Issue.6
, pp. 1246-1254
-
-
Hochberg, M.C.1
Ross, P.D.2
Black, D.3
Cummings, S.R.4
Genant, H.K.5
Nevitt, M.C.6
Barrett-Connor, E.7
Musliner, T.8
Thompson, D.9
-
24
-
-
1442285904
-
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Prevention and Treatment of Postmenopausal Osteoporosis: 2001 Edition, with selected updates for 2003
-
AACE Osteoporosis Task Force
-
Hodgson SF, Watts NB, Bilezikian JP, Clarke BL, Gray TK, Harris DW, Johnston CC Jr, Kleerekoper M, Lindsay R, Luckey MM, McClung MR, Nankin HR, Petak SM, Recker RR; AACE Osteoporosis Task Force. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Prevention and Treatment of Postmenopausal Osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract. 2003;9: 544-564.
-
Endocr Pract
, vol.2003
, Issue.9
, pp. 544-564
-
-
Hodgson, S.F.1
Watts, N.B.2
Bilezikian, J.P.3
Clarke, B.L.4
Gray, T.K.5
Harris, D.W.6
Johnston Jr., C.C.7
Kleerekoper, M.8
Lindsay, R.9
Luckey, M.M.10
McClung, M.R.11
Nankin, H.R.12
Petak, S.M.13
Recker, R.R.14
-
25
-
-
77952713411
-
Approach to the patient with secondary osteoporosis
-
Hofbauer LC, Hamann C, Ebeling PR. Approach to the patient with secondary osteoporosis. Eur J Endocrinol. 2010;162:1009-1020.
-
(2010)
Eur J Endocrinol
, vol.162
, pp. 1009-1020
-
-
Hofbauer, L.C.1
Hamann, C.2
Ebeling, P.R.3
-
26
-
-
33845912113
-
Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis
-
DOI 10.1007/s10067-006-0252-z
-
Iwamoto J, Takeda T, Sato Y, Uzawa M. Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis. Clin Rheumatol. 2007;26:161-167. (Pubitemid 46020236)
-
(2007)
Clinical Rheumatology
, vol.26
, Issue.2
, pp. 161-167
-
-
Iwamoto, J.1
Takeda, T.2
Sato, Y.3
Uzawa, M.4
-
27
-
-
0034755030
-
Mortality, morbidity, and assessment of fracture risk in male osteoporosis
-
DOI 10.1007/s00223-001-1045-7
-
Johnell O, Kanis J, Gullberg G. Mortality, morbidity, and assessment of fracture risk in male osteoporosis. Calcif Tissue Int. 2001;69:182-184. (Pubitemid 33035382)
-
(2001)
Calcified Tissue International
, vol.69
, Issue.4
, pp. 182-184
-
-
Johnell, O.1
Kanis, J.2
Gullberg, G.3
-
28
-
-
77949354742
-
Excess mortality in men compared with women following a hip fracture: National analysis of comedications, comorbidity and survival
-
Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B. Excess mortality in men compared with women following a hip fracture: national analysis of comedications, comorbidity and survival. Age Ageing. 2010;39:203-209.
-
(2010)
Age Ageing
, vol.39
, pp. 203-209
-
-
Kannegaard, P.N.1
Van Der Mark, S.2
Eiken, P.3
Abrahamsen, B.4
-
29
-
-
22844447275
-
Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: Treatment and discontinuation of therapy
-
Kaufman JM, Orwoll E, Goemaere S, San Martin J, Hossain A, Dalsky GP, Lindsay R, Mitlak BH. Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy. Osteoporos Int. 2005;16:510-516.
-
(2005)
Osteoporos Int
, vol.16
, pp. 510-516
-
-
Kaufman, J.M.1
Orwoll, E.2
Goemaere, S.3
San Martin, J.4
Hossain, A.5
Dalsky, G.P.6
Lindsay, R.7
Mitlak, B.H.8
-
30
-
-
0037190692
-
Undertreatment of osteoporosis in men with hip fracture
-
DOI 10.1001/archinte.162.19.2217
-
Kiebzak GM, Beinart GA, Perser K, Ambrose CG, Siff SJ, Heggeness MH. Undertreatment of osteoporosis in men with hip fracture. Arch Intern Med. 2002;162:2217-2222. (Pubitemid 35231591)
-
(2002)
Archives of Internal Medicine
, vol.162
, Issue.19
, pp. 2217-2222
-
-
Kiebzak, G.M.1
Beinart, G.A.2
Perser, K.3
Ambrose, C.G.4
Siff, S.J.5
Heggeness, M.H.6
-
31
-
-
73649122393
-
Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis?
-
Kolios L, Hoerster AK, Sehmisch S, Malcherek MC, Rack T, Tezval M, Seidlova-Wuttke D, Wuttke W, Stuermer KM, Stuermer EK. Do estrogen and alendronate improve metaphyseal fracture healing when applied as osteoporosis prophylaxis? Calcif Tissue Int. 2010;86:23-32.
-
(2010)
Calcif Tissue Int
, vol.86
, pp. 23-32
-
-
Kolios, L.1
Hoerster, A.K.2
Sehmisch, S.3
Malcherek, M.C.4
Rack, T.5
Tezval, M.6
Seidlova-Wuttke, D.7
Wuttke, W.8
Stuermer, K.M.9
Stuermer, E.K.10
-
32
-
-
67650468390
-
Association of low-energy femoral fractures with prolonged bisphosphonate use: A case control study
-
Lenart BA, Neviaser AS, Lyman S, Chang CC, Edobor-Osula F, Steele B, van der Meulen MC, Lorich DG, Lane JM. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int. 2009;20: 1353-1362.
-
(2009)
Osteoporos Int
, vol.20
, pp. 1353-1362
-
-
Lenart, B.A.1
Neviaser, A.S.2
Lyman, S.3
Chang, C.C.4
Edobor-Osula, F.5
Steele, B.6
Van Der Meulen, M.C.7
Lorich, D.G.8
Lane, J.M.9
-
33
-
-
33646533981
-
Sex-specific regulation of growth plate chondrocytes by estrogen is via multiple MAP kinase signaling pathways
-
McMillan J, Fatehi-Sedeh S, Sylvia VL, Bingham V, Zhong M, Boyan BD, Schwartz Z. Sex-specific regulation of growth plate chondrocytes by estrogen is via multiple MAP kinase signaling pathways. Biochim Biophys Acta. 2006;1963:381-392.
-
(2006)
Biochim Biophys Acta
, vol.1963
, pp. 381-392
-
-
McMillan, J.1
Fatehi-Sedeh, S.2
Sylvia, V.L.3
Bingham, V.4
Zhong, M.5
Boyan, B.D.6
Schwartz, Z.7
-
34
-
-
3242691241
-
Patterns of bone mineral density testing: Current guidelines, testing rates, and interventions
-
DOI 10.1111/j.1525-1497.2004.30240.x
-
Morris CA, Cabral D, Cheng H, Katz JN, Finkelstein JS, Avorn J, Solomon DH. Patterns of bone mineral density testing: current guidelines, testing rates, and interventions. J Gen Intern Med. 2004;19:783-790. (Pubitemid 38951953)
-
(2004)
Journal of General Internal Medicine
, vol.19
, Issue.7
, pp. 783-790
-
-
Morris, C.A.1
Cabral, D.2
Cheng, H.3
Katz, J.N.4
Finkelstein, J.S.5
Avorn, J.6
Solomon, D.H.7
-
35
-
-
0035837553
-
Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis
-
Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434-1441.
-
(2001)
N Engl J Med
, vol.344
, pp. 1434-1441
-
-
Neer, R.M.1
Arnaud, C.D.2
Zanchetta, J.R.3
Prince, R.4
Gaich, G.A.5
Reginster, J.Y.6
Hodsman, A.B.7
Eriksen, E.F.8
Ish-Shalom, S.9
Genant, H.K.10
Wang, O.11
Mitlak, B.H.12
-
36
-
-
79959559306
-
Screening for Osteoporosis: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation [Internet]
-
Rockville, MD: Agency for Healthcare Research and Quality
-
Nelson HD, Haney EM, Chou R, Dana T, Fu R, Bougatsos C. Screening for Osteoporosis: Systematic Review to Update the 2002 U.S. Preventive Services Task Force Recommendation [Internet]. AHRQ Report Number 10-05145-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2010.
-
(2010)
AHRQ Report Number 10-05145-EF-1
-
-
Nelson, H.D.1
Haney, E.M.2
Chou, R.3
Dana, T.4
Fu, R.5
Bougatsos, C.6
-
37
-
-
43049129258
-
Low-energy femoral shaft fractures associated with alendronate use
-
DOI 10.1097/BOT.0b013e318172841c, PII 0000513120080500000011
-
Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG. Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008;22:346-350. (Pubitemid 351630250)
-
(2008)
Journal of Orthopaedic Trauma
, vol.22
, Issue.5
, pp. 346-350
-
-
Neviaser, A.S.1
Lane, J.M.2
Lenart, B.A.3
Edobor-Osula, F.4
Lorich, D.G.5
-
39
-
-
0034739277
-
Alendronate for the treatment of osteoporosis in men
-
DOI 10.1056/NEJM200008313430902
-
Orwoll E, Ettinger M, Weiss S, Miller P, Kendler D, Graham J, Adami S, Weber K, Lorenc R, Pietschmann P, Vandormael K, Lombardi A. Alendronate for the treatment of osteoporosis in men. N Engl J Med. 2000;343:604-610. (Pubitemid 30659471)
-
(2000)
New England Journal of Medicine
, vol.343
, Issue.9
, pp. 604-610
-
-
Orwoll, E.1
Ettinger, M.2
Weiss, S.3
Miller, P.4
Kendler, D.5
Graham, J.6
Adami, S.7
Weber, K.8
Lorenc, R.9
Pietschmann, P.10
Vandormael, K.11
Lombardi, A.12
-
40
-
-
0037214255
-
The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis
-
DOI 10.1359/jbmr.2003.18.1.9
-
Orwoll ES, Scheele WH, Paul S, Adami S, Syversen U, Diez-Perez A, Kaufman JM, Clancy AD, Gaich GA. The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res. 2003;18:9-17. (Pubitemid 36008334)
-
(2003)
Journal of Bone and Mineral Research
, vol.18
, Issue.1
, pp. 9-17
-
-
Orwoll, E.S.1
Scheele, W.H.2
Paul, S.3
Adami, S.4
Syversen, U.5
Diez-Perez, A.6
Kaufman, J.-M.7
Clancy, A.D.8
Gaich, G.A.9
-
41
-
-
34848819692
-
A Review of the Literature on Osteonecrosis of the Jaw in Patients with Osteoporosis Treated with Oral Bisphosphonates: Prevalence, Risk Factors, and Clinical Characteristics
-
DOI 10.1016/j.clinthera.2007.08.008, PII S0149291807002433
-
Pazianas M, Miller P, Blumentals WA, Bernal M, Kothawala P. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther. 2007;29: 1548-1558. (Pubitemid 47500128)
-
(2007)
Clinical Therapeutics
, vol.29
, Issue.8
, pp. 1548-1558
-
-
Pazianas, M.1
Miller, P.2
Blumentals, W.A.3
Bernal, M.4
Kothawala, P.5
-
42
-
-
62749156411
-
Influence of intramedullary nail diameter and locking mode on the stability of tibial shaft fracture fixation
-
Penzkofer R, Maier M, Nolte A, von Oldenburg G, Puschel K, Buhren V, Augat P. Influence of intramedullary nail diameter and locking mode on the stability of tibial shaft fracture fixation. Arch Orthop Trauma Surg. 2009;129:525-531.
-
(2009)
Arch Orthop Trauma Surg
, vol.129
, pp. 525-531
-
-
Penzkofer, R.1
Maier, M.2
Nolte, A.3
Von Oldenburg, G.4
Puschel, K.5
Buhren, V.6
Augat, P.7
-
43
-
-
0032896590
-
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: Results of the FOSIT study
-
DOI 10.1007/PL00004171
-
Pols HA, Felsenberg D, Hanley DA, Stepan J, Munoz-Torres M, Wilkin TJ, Qin-sheng G, Galich AM, Vandormael K, Yates AJ, Stych B; Fosamax International Trial Study Group. Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Osteoporos Int. 1999;9:461-468. (Pubitemid 29231740)
-
(1999)
Osteoporosis International
, vol.9
, Issue.5
, pp. 461-468
-
-
Pols, H.A.P.1
Felsenberg, D.2
Hanley, D.A.3
Stepan, J.4
Munoz-Torres, M.5
Wilkin, T.J.6
Qin-Sheng, G.7
Galich, A.M.8
Vandormael, K.9
Yates, A.J.10
Stych, B.11
-
44
-
-
23844475165
-
Sexual dimorphism of growth plate prehypertrophic and hypertrophic chondrocytes in response to testosterone requires metabolism to dihydrotestosterone (DHT) by steroid 5-alpha reductase type 1
-
DOI 10.1002/jcb.20298
-
Raz P, Nasatzky E, Boyan BD, Ornoy A, Schwartz Z. Sexual dimorphism of growth plate prehypertrophic and hypertrophic chondrocytes in response to testosterone requires metabolism to dihydrotestosterone (DHT) by steroid 5-alpha reductase type 1. J Cell Biochem. 2005;95:108-119. (Pubitemid 41420221)
-
(2005)
Journal of Cellular Biochemistry
, vol.95
, Issue.1
, pp. 108-119
-
-
Raz, P.1
Nasatzky, E.2
Boyan, B.D.3
Ornoy, A.4
Schwartz, Z.5
-
45
-
-
57649199627
-
Sustained efficacy of risedronate in men with primary and secondary osteoporosis: Results of a 2-year study
-
Ringe JD, Farahmand P, Faber H, Dorst A. Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. Rheumatol Int. 2009;29:311-315.
-
(2009)
Rheumatol Int
, vol.29
, pp. 311-315
-
-
Ringe, J.D.1
Farahmand, P.2
Faber, H.3
Dorst, A.4
-
46
-
-
0036117810
-
Treatment of male osteoporosis: Recent advances with alendronate
-
DOI 10.1007/s001980200013
-
Ringe JD, Orwoll E, Daifotis A, Lombardi A. Treatment of male osteoporosis: recent advances with alendronate. Osteoporos Int. 2002;13:195-199. (Pubitemid 34408184)
-
(2002)
Osteoporosis International
, vol.13
, Issue.3
, pp. 195-199
-
-
Ringe, J.D.1
Orwoll, E.2
Daifotis, A.3
Lombardi, A.4
-
47
-
-
0037125379
-
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
-
Writing Group for the Women's Health Initiative Investigators
-
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-333.
-
(2002)
JAMA
, vol.288
, pp. 321-333
-
-
Rossouw, J.E.1
Anderson, G.L.2
Prentice, R.L.3
LaCroix, A.Z.4
Kooperberg, C.5
Stefanick, M.L.6
Jackson, R.D.7
Beresford, S.A.8
Howard, B.V.9
Johnson, K.C.10
Kotchen, J.M.11
Ockene, J.12
-
48
-
-
33749165562
-
Vitamin D and intact PTH status in patients with hip fracture
-
DOI 10.1007/s00198-006-0167-1
-
Sakuma M, Endo N, Oinuma T, Hayami T, Endo E, Yazawa T, Watanabe K, Watanabe S. Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int. 2006;17:1608-1614. (Pubitemid 44477620)
-
(2006)
Osteoporosis International
, vol.17
, Issue.11
, pp. 1608-1614
-
-
Sakuma, M.1
Endo, N.2
Oinuma, T.3
Hayami, T.4
Endo, E.5
Yazawa, T.6
Watanabe, K.7
Watanabe, S.8
-
49
-
-
23944439722
-
Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women
-
Sawka AM, Papaioannou A, Adachi JD, Gafni A, Hanley DA, Thabane L. Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women. BMC Musculoskelet Disord. 2005;6:39.
-
(2005)
BMC Musculoskelet Disord
, vol.6
, pp. 39
-
-
Sawka, A.M.1
Papaioannou, A.2
Adachi, J.D.3
Gafni, A.4
Hanley, D.A.5
Thabane, L.6
-
50
-
-
0034751519
-
Clinical review 137: Sexual dimorphism in skeletal size, density, and strength
-
DOI 10.1210/jc.86.10.4576
-
Seeman E. Clinical Review 137: Sexual dimorphism in skeletal size, density, and strength. J Clin Endocrinol Metab. 2001;86: 4576-4584. (Pubitemid 33020488)
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.10
, pp. 4576-4584
-
-
Seeman, E.1
-
51
-
-
0034121294
-
Estrogen replacement therapy and the surgeon
-
DOI 10.1016/S0002-9610(00)00331-7, PII S0002961000003317
-
Shackelford DP, Lalikos JF. Estrogen replacement therapy and the surgeon. Am J Surg. 2000;179:333-336. (Pubitemid 30394700)
-
(2000)
American Journal of Surgery
, vol.179
, Issue.4
, pp. 333-336
-
-
Shackelford, D.P.1
Lalikos, J.F.2
-
52
-
-
78349249359
-
Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the American Society for Bone and Mineral Research
-
American Society for Bone and Mineral Research
-
Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster D, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Koval K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Sen HT, Van Der Meulen MC, Weinstein RS, Whyte M; American Society for Bone and Mineral Research. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010;25:2267-2294.
-
(2010)
J Bone Miner Res
, vol.25
, pp. 2267-2294
-
-
Shane, E.1
Burr, D.2
Ebeling, P.R.3
Abrahamsen, B.4
Adler, R.A.5
Brown, T.D.6
Cheung, A.M.7
Cosman, F.8
Curtis, J.R.9
Dell, R.10
Dempster, D.11
Einhorn, T.A.12
Genant, H.K.13
Geusens, P.14
Klaushofer, K.15
Koval, K.16
Lane, J.M.17
McKiernan, F.18
McKinney, R.19
Ng, A.20
Nieves, J.21
O'Keefe, R.22
Papapoulos, S.23
Sen, H.T.24
Van Der Meulen, M.C.25
Weinstein, R.S.26
Whyte, M.27
more..
-
53
-
-
37549063366
-
Recommendations for the clinical evaluation of agents for treatment of osteoporosis: Consensus of an expert panel representing the American Society for Bone and Mineral Research (ASBMR), the International Society for Clinical Densitometry (ISCD), and the National Osteoporosis Foundation (NOF)
-
Consensus Panel of the ASBMR, ISCD, and NOF
-
Silverman SL, Cummings SR, Watts NB; Consensus Panel of the ASBMR, ISCD, and NOF. Recommendations for the clinical evaluation of agents for treatment of osteoporosis: consensus of an expert panel representing the American Society for Bone and Mineral Research (ASBMR), the International Society for Clinical Densitometry (ISCD), and the National Osteoporosis Foundation (NOF). J Bone Miner Res. 2008;23: 159-165.
-
(2008)
J Bone Miner Res
, vol.23
, pp. 159-165
-
-
Silverman, S.L.1
Cummings, S.R.2
Watts, N.B.3
-
54
-
-
0028143234
-
Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man
-
DOI 10.1056/NEJM199410203311604
-
Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med. 1994;331:1056-1061. (Pubitemid 24317698)
-
(1994)
New England Journal of Medicine
, vol.331
, Issue.16
, pp. 1056-1061
-
-
Smith, E.P.1
Boyd, J.2
Frank, G.R.3
Takahashi, H.4
Cohen, R.M.5
Specker, B.6
Williams, T.C.7
Lubahn, D.B.8
Korach, K.S.9
-
55
-
-
77950892876
-
Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis: A new fracture-healing model at the tibia in rat
-
Stuermer EK, Sehmisch S, Rack T, Wenda E, Seidlova-Wuttke D, Tezval M, Wuttke W, Frosch KH, Stuermer KM. Estrogen and raloxifene improve metaphyseal fracture healing in the early phase of osteoporosis: a new fracture-healing model at the tibia in rat. Langenbecks Arch Surg. 2010;395:163-172.
-
(2010)
Langenbecks Arch Surg
, vol.395
, pp. 163-172
-
-
Stuermer, E.K.1
Sehmisch, S.2
Rack, T.3
Wenda, E.4
Seidlova-Wuttke, D.5
Tezval, M.6
Wuttke, W.7
Frosch, K.H.8
Stuermer, K.M.9
-
56
-
-
0035145739
-
Bioavailable estradiol may be an important determinant of osteoporosis in men: The MINOS study
-
DOI 10.1210/jc.86.1.192
-
Szulc P, Munoz F, Claustrat B, Garnero P, Marchand F, Duboeuf F, Delmas PD. Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J Clin Endocrinol Metab. 2001;86:192-199. (Pubitemid 32109796)
-
(2001)
Journal of Clinical Endocrinology and Metabolism
, vol.86
, Issue.1
, pp. 192-199
-
-
Szulc, P.1
Munoz, F.2
Claustrat, B.3
Garnero, P.4
Marchand, F.5
Duboeuf, F.6
Delmas, P.D.7
-
57
-
-
34548047185
-
Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: A meta-analysis
-
DOI 10.1016/S0140-6736(07)61342-7, PII S0140673607613427
-
Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007;370:657-666. (Pubitemid 47285316)
-
(2007)
Lancet
, vol.370
, Issue.9588
, pp. 657-666
-
-
Tang, B.M.1
Eslick, G.D.2
Nowson, C.3
Smith, C.4
Bensoussan, A.5
-
58
-
-
21444447157
-
Does sex matter in musculoskeletal health? The influence of sex and gender on musculoskeletal health
-
DOI 10.2106/JBJS.E.00218
-
Tosi LL, Boyan BD, Boskey AL. Does sex matter in musculoskeletal health? The influence of sex and gender on musculoskeletal health. J Bone Joint Surg Am. 2005;87:1631-1647. (Pubitemid 40917768)
-
(2005)
Journal of Bone and Joint Surgery - Series A
, vol.87
, Issue.7
, pp. 1631-1647
-
-
Tosi, L.L.1
Boyan, B.D.2
Boskey, A.L.3
-
59
-
-
79959540449
-
Influence of age and sex steroids on bone density and geometry in middle-aged and elderly European men
-
The EMAS Study Group. October 30 [Epub ahead of print]
-
Ward KA, Pye SR, Adams JE, Boonen S, Vanderschueren D, Borghs H, Gaytant J, Gielen E, Bartfai G, Casanueva FF, Finn JD, Forti G, Giwercman A, Han TS, Huhtaniemi IT, Kula K, Labrie F, Lean ME, Pendleton N, Punab M, Silman AJ, Wu FC, O'Neill TW; The EMAS Study Group. Influence of age and sex steroids on bone density and geometry in middle-aged and elderly European men. Osteoporos Int. 2010 October 30 [Epub ahead of print].
-
(2010)
Osteoporos Int
-
-
Ward, K.A.1
Pye, S.R.2
Adams, J.E.3
Boonen, S.4
Vanderschueren, D.5
Borghs, H.6
Gaytant, J.7
Gielen, E.8
Bartfai, G.9
Casanueva, F.F.10
Finn, J.D.11
Forti, G.12
Giwercman, A.13
Han, T.S.14
Huhtaniemi, I.T.15
Kula, K.16
Labrie, F.17
Lean, M.E.18
Pendleton, N.19
Punab, M.20
Silman, A.J.21
Wu, F.C.22
O'Neill, T.W.23
more..
|